Showing results for "Sinopharm"
business
US Investors Aim Low to Hit Highs in English FootballHi it’s David Hellier in London, looking at the ever-expanding network of US owners across all levels of UK football. Also today, another US IPO prices at the bottom of its range and a private equity veteran departs Goldman Sachs.February 7, 2024
markets
Sinopharm Said to Renew Pursuit of Possible China TCM BuyoutChina National Pharmaceutical Group Co. is considering potentially taking China Traditional Chinese Medicine Holdings Co. private, according to people familiar with the matter, having abandoned a previous attempt to do so in 2022.February 7, 2024
technology
China Says Homegrown mRNA Covid Shot is a Preferred BoosterChina said its recently-approved first homegrown mRNA Covid vaccine was one of its two preferred boosters, potentially encouraging more people to get their follow-up shots amid a renewed government campaign to shore up immunity.April 10, 2023
markets
China Approves Merck’s Covid Therapy Amid Shortage of DrugsChina has approved Merck & Co’s Covid-19 antiviral molnupiravir for emergency use as Beijing seeks to expand access to treatments amid a massive wave of infections following its abrupt pivot away from Covid Zero in early December.December 30, 2022